Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-32,100
Closed -$5.21M 2756
2015
Q4
$5.21M Sell
32,100
-37,400
-54% -$5.88M 0.09% 134
2015
Q3
$9.61M Buy
69,500
+32,700
+89% +$5.15M 0.16% 60
2015
Q2
$5.65M Buy
36,800
+4,800
+15% +$769K 0.1% 110
2015
Q1
$5.12M Sell
32,000
-9,400
-23% -$1.48M 0.1% 118
2014
Q4
$6.59M Sell
41,400
-700
-2% -$109K 0.11% 92
2014
Q3
$5.91M Sell
42,100
-14,100
-25% -$1.84M 0.11% 115
2014
Q2
$6.65M Sell
56,200
-13,000
-19% -$1.5M 0.1% 117
2014
Q1
$8.54M Sell
69,200
-3,500
-5% -$424K 0.11% 137
2013
Q4
$8.29M Buy
72,700
+900
+1% +$102K 0.09% 112
2013
Q3
$8.04M Buy
+71,800
New +$7.79M 0.1% 124

Other funds holding AMGN

Virtu KCG Holdings's AMGN Position: Q2 2017 in Review

Virtu KCG Holdings increased its Amgen (AMGN) stake by 18% in Q2 2017, buying an estimated $678K and bringing the position to 26,738 shares worth $4.61M. The position accounts for 0.13% of the portfolio, ranked #70.

Virtu KCG Holdings first reported a position in AMGN in Q3 2013 and has held it in 16 quarters since. The position peaked at $13.2M in Q3 2016. 1,595 funds tracked by Wall St. Rank hold AMGN as of Q2 2017.

  • Virtu KCG Holdings held 26,738 shares of Amgen worth $4.61M as of Q2 2017.
  • Virtu KCG Holdings bought 4,168 Amgen shares in Q2 2017, an estimated $678K.
  • Amgen made up 0.13% of Virtu KCG Holdings's portfolio in Q2 2017, its #70 holding.
  • Virtu KCG Holdings first reported a position in Amgen in Q3 2013 and has held it in 16 quarters since.
  • Virtu KCG Holdings's Amgen position peaked at $13.2M in Q3 2016.
  • 1,595 funds tracked by Wall St. Rank held Amgen as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.